We present a deterministic model of the possible emergence of a vaccine esc
ape variant of hepatitis B virus (HBV). The model identifies the key unknow
ns determining this process: the protection afforded by she current vaccine
s against particular HBV variants; the infectiousness of these variants; an
d the current prevalence of individuals infectious with the variants (each
factor relative to wild-type). By malting pessimistic assumptions about the
se unknowns we show that even a highly infectious variant, under a vaccine
programme that affords no protection against the variant, would still take
decades to emerge. Thus the current low prevalence of variants is not evide
nce for the cross-reactivity of the current vaccines or for a lack of infec
tiousness in the variants. As any vaccine failure will be inapparent for de
cades it may be sensible to recommend vaccine modifications now rather than
later.